Using ultrasound at acupoints to treat polycystic ovary syndrome
Effect of Ultrasound Acupoints on Patients With Polycystic Ovary Syndrome
NA · Kafrelsheikh University · NCT06844903
This study is testing if using ultrasound at acupuncture points can help women with polycystic ovary syndrome improve their menstrual cycles and hormone levels.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 44 (estimated) |
| Ages | 18 Years to 35 Years |
| Sex | Female |
| Sponsor | Kafrelsheikh University (other) |
| Locations | 1 site (Mansoura) |
| Trial ID | NCT06844903 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of pulsed ultrasound applied at acupuncture points on menstrual irregularities and hormone levels in patients with polycystic ovary syndrome (PCOS). PCOS is a common endocrine disorder that can lead to infertility and is characterized by hormonal imbalances. The study aims to explore a novel approach using ultrasound acupoint therapy as an alternative to standard pharmacological treatments, which are only effective in a subset of patients. Participants will receive either active or placebo ultrasound treatment alongside standard care.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 to 35 with symptoms of oligomenorrhea or amenorrhea and a BMI not exceeding 30 kg/m2.
Not a fit: Patients with severe cardiorespiratory or musculoskeletal diseases, malignancies, or those who cannot stop medications affecting the study will not benefit.
Why it matters
Potential benefit: If successful, this approach could provide a non-invasive treatment option for managing PCOS symptoms and improving reproductive health.
How similar studies have performed: While acupuncture has shown benefits in treating PCOS, this specific approach using ultrasound acupoints is novel and has not been previously tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults range between 18 and 35 years. * All patients will be stopped drugs that affect the result during study period. * body mass index (BMI) not exceeding 30 kg/m2. * have the symptoms of oligomenorrhea or amenorrhea (appendix I). * No documented or observable psychiatric or neurological disorders that would interfere with study participation (eg, dementia or psychosis). * Not having any type of cancer. Exclusion Criteria: * Any malignancy * Patients with severe or unstable cardiorespiratory or musculoskeletal diseases that may influence the accuracy of quantitative sensory testing results. * Participants who refuse to stop the drugs that affect the study during study period. * Contraindications to therapeutic ultrasound including active cancer in region of hands or feet, presence of deep vein thrombosis, complete numbness in hands or feet, metal or plastic implantation.
Where this trial is running
Mansoura
- outpatient clinics of Mansoura Hospital — Mansoura, Egypt (RECRUITING)
Study contacts
- Study coordinator: Ola Fathy Elsayed Atwa Elsharabasy, B.Sc
- Email: olafathy131995@gmail.com
- Phone: +20 10 64915762
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Polycystic Ovary Syndrome